Versavo 400 mg Injection
  1. Home
  2. Pharma Products
  3. Dr Reddy 's Laboratories Ltd
  4. Versavo 400 mg Injection

Versavo 400 mg Injection

Versavo 400 mg Injection contains bevacizumab 400 mg, a targeted anticancer medicine used for several advanced or metastatic cancers. It is administered as an intravenous infusion by a qualified healthcare professional. Bevacizumab blocks VEGF-A, helping inhibit the formation of new blood vessels that support tumor growth.

BUY NOW

Category

Versavo 400 mg Injection is used in treatment regimens for conditions including colorectal, lung, kidney, ovarian, cervical, and other advanced cancers. Bevacizumab is a recombinant humanized monoclonal antibody that binds to VEGF-A and suppresses tumor angiogenesis. It may be given alone or with chemotherapy or other anticancer medicines depending on the specific treatment protocol. The dose and administration schedule are determined by the treating oncologist according to the patient’s condition and treatment regimen.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 400 mg
Dosage Form Concentrate for Solution for Infusion
Route Intravenous Infusion
Pack Size 1 Vial of 16 mL
Manufacturer/Marketer Dr. Reddy’s Laboratories Ltd.

Product Also Known As

Versavo 400 mg Injection, Versavo 400 Injection, Versavo Bevacizumab Injection, Bevacizumab 400 mg Injection, Bevacizumab Anti-Cancer Injection, Bevacizumab VEGF Inhibitor Injection